BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9328808)

  • 21. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulant abuse treatment as HIV prevention.
    Shoptaw S; Reback CJ; Frosch DL; Rawson RA
    J Addict Dis; 1998; 17(4):19-32. PubMed ID: 9848029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
    Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
    Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methamphetamine abuse and emergency department utilization.
    Richards JR; Bretz SW; Johnson EB; Turnipseed SD; Brofeldt BT; Derlet RW
    West J Med; 1999 Apr; 170(4):198-202. PubMed ID: 10344172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subjective responses to initial experience with cocaine: an exploration of the incentive-sensitization theory of drug abuse.
    Lambert NM; McLeod M; Schenk S
    Addiction; 2006 May; 101(5):713-25. PubMed ID: 16669905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment response by primary drug of abuse: does methamphetamine make a difference?
    Luchansky B; Krupski A; Stark K
    J Subst Abuse Treat; 2007 Jan; 32(1):89-96. PubMed ID: 17175402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meth mouth: a review of methamphetamine abuse and its oral manifestations.
    Curtis EK
    Gen Dent; 2006; 54(2):125-9; quiz 130. PubMed ID: 16689071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular mechanism for methamphetamine-induced memory impairment].
    Nagai T; Yamada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Apr; 45(2):81-91. PubMed ID: 20486560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why do we need an Addiction supplement focused on methamphetamine?
    Rawson RA; Condon TP
    Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users.
    Kim DJ; Roh S; Kim Y; Yoon SJ; Lee HK; Han CS; Kim YK
    Neurosci Lett; 2005 Nov; 388(2):112-5. PubMed ID: 16039058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine abuse: medical and dental considerations.
    Smart RJ; Rosenberg M
    J Mass Dent Soc; 2005; 54(2):44-6, 48-9. PubMed ID: 16149403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Explanations for methamphetamine use among gay and bisexual men in New York City.
    Halkitis PN; Fischgrund BN; Parsons JT
    Subst Use Misuse; 2005; 40(9-10):1331-45. PubMed ID: 16048820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological differences between binge and chronic methamphetamine using gay and bisexual men.
    Halkitis PN; Shrem MT
    Addict Behav; 2006 Mar; 31(3):549-52. PubMed ID: 15967585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nature, time course and severity of methamphetamine withdrawal.
    McGregor C; Srisurapanont M; Jittiwutikarn J; Laobhripatr S; Wongtan T; White JM
    Addiction; 2005 Sep; 100(9):1320-9. PubMed ID: 16128721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine use by incarcerated women: comorbid mood and anxiety problems.
    Vik PW
    Womens Health Issues; 2007; 17(4):256-63. PubMed ID: 17544297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.